AAAAAA

   
Results: 1-25 | 26-50 | 51-63
Results: 1-25/63
SEGREGATION ANALYSIS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND FIBRINOGEN LEVELS IN THE NHLBI FAMILY HEART-STUDY
Authors: PANKOW JS FOLSOM AR PROVINCE MA RAO DC WILLIAMS RR ECKFELDT J SELLERS TA
Citation: Js. Pankow et al., SEGREGATION ANALYSIS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND FIBRINOGEN LEVELS IN THE NHLBI FAMILY HEART-STUDY, Arteriosclerosis, thrombosis, and vascular biology, 18(10), 1998, pp. 1559-1567
ONCE-A-DAY LEVOFLOXACIN IN THE TREATMENT OF MILD-TO-MODERATE AND SEVERE COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS
Authors: FOGARTY CT SULLIVAN JG CHATTMAN MS WILLIAMS RR KOJAK G RUBIN A
Citation: Ct. Fogarty et al., ONCE-A-DAY LEVOFLOXACIN IN THE TREATMENT OF MILD-TO-MODERATE AND SEVERE COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS, Infectious diseases in clinical practice, 7(8), 1998, pp. 400-407
MULTICENTER, RANDOMIZED STUDY COMPARING EFFICACY AND SAFETY OF ORAL LEVOFLOXACIN AND CEFACLOR IN TREATMENT OF ACUTE BACTERIAL EXACERBATIONSOF CHRONIC-BRONCHITIS
Authors: HABIB MP GENTRY LO RODRIGUEZGOMEZ G MOROWITZ W POLAK E RAE JK MORGAN NS WILLIAMS RR
Citation: Mp. Habib et al., MULTICENTER, RANDOMIZED STUDY COMPARING EFFICACY AND SAFETY OF ORAL LEVOFLOXACIN AND CEFACLOR IN TREATMENT OF ACUTE BACTERIAL EXACERBATIONSOF CHRONIC-BRONCHITIS, Infectious diseases in clinical practice, 7(2), 1998, pp. 101-109
MODELING DISEASE INCIDENCE RATES IN FAMILIES
Authors: SIEGMUND KD PROVINCE MA HIGGINS M WILLIAMS RR KELLER J TODOROV AA
Citation: Kd. Siegmund et al., MODELING DISEASE INCIDENCE RATES IN FAMILIES, Epidemiology, 9(5), 1998, pp. 557-562
FIBRINOGEN, PLASMINOGEN-ACTIVATOR INHIBITOR-1, AND CAROTID INTIMA-MEDIA WALL THICKNESS IN THE NHLBI FAMILY HEART-STUDY
Authors: FOLSOM AR PANKOW JS WILLIAMS RR EVANS GW PROVINCE MA ECKFELDT JH
Citation: Ar. Folsom et al., FIBRINOGEN, PLASMINOGEN-ACTIVATOR INHIBITOR-1, AND CAROTID INTIMA-MEDIA WALL THICKNESS IN THE NHLBI FAMILY HEART-STUDY, Thrombosis and haemostasis, 79(2), 1998, pp. 400-404
ANGIOTENSINOGEN GENOTYPE, SODIUM REDUCTION, WEIGHT-LOSS, AND PREVENTION OF HYPERTENSION - TRIALS OF HYPERTENSION PREVENTION, PHASE-II
Authors: HUNT SC COOK NR OBERMAN A CUTLER JA HENNEKENS CH ALLENDER PS WALKER WG WHELTON PK WILLIAMS RR
Citation: Sc. Hunt et al., ANGIOTENSINOGEN GENOTYPE, SODIUM REDUCTION, WEIGHT-LOSS, AND PREVENTION OF HYPERTENSION - TRIALS OF HYPERTENSION PREVENTION, PHASE-II, Hypertension, 32(3), 1998, pp. 393-401
INCREASED URINARY FREE CORTISOL - A POTENTIAL INTERMEDIATE PHENOTYPE OF ESSENTIAL-HYPERTENSION
Authors: LITCHFIELD WR HUNT SC JEUNEMAITRE X FISHER NDL HOPKINS PN WILLIAMS RR CORVOL P WILLIAMS GH
Citation: Wr. Litchfield et al., INCREASED URINARY FREE CORTISOL - A POTENTIAL INTERMEDIATE PHENOTYPE OF ESSENTIAL-HYPERTENSION, Hypertension, 31(2), 1998, pp. 569-574
LEVOFLOXACIN DOES NOT ALTER CYCLOSPORINE DISPOSITION
Authors: DOOSE DR WALKER SA CHIEN SC WILLIAMS RR NAYAK RK
Citation: Dr. Doose et al., LEVOFLOXACIN DOES NOT ALTER CYCLOSPORINE DISPOSITION, Journal of clinical pharmacology, 38(1), 1998, pp. 90-93
DOUBLE-BLIND EVALUATION OF THE SAFETY AND PHARMACOKINETICS OF MULTIPLE ORAL ONCE-DAILY 750-MILLIGRAM AND 1-GRAM DOSES OF LEVOFLOXACIN IN HEALTHY-VOLUNTEERS
Authors: CHIEN SC WONG FA FOWLER CL CALLERYDAMICO SV WILLIAMS RR NAYAK R CHOW AT
Citation: Sc. Chien et al., DOUBLE-BLIND EVALUATION OF THE SAFETY AND PHARMACOKINETICS OF MULTIPLE ORAL ONCE-DAILY 750-MILLIGRAM AND 1-GRAM DOSES OF LEVOFLOXACIN IN HEALTHY-VOLUNTEERS, Antimicrobial agents and chemotherapy, 42(4), 1998, pp. 885-888
LACK OF ASSOCIATION BETWEEN PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR P1(A) POLYMORPHISM AND CORONARY-ARTERY DISEASE OR CAROTID INTIMA-MEDIA THICKNESS/
Authors: GARG UC ARNETT DK FOLSOM AR PROVINCE MA WILLIAMS RR ECKFELDT JH
Citation: Uc. Garg et al., LACK OF ASSOCIATION BETWEEN PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR P1(A) POLYMORPHISM AND CORONARY-ARTERY DISEASE OR CAROTID INTIMA-MEDIA THICKNESS/, Thrombosis research, 89(2), 1998, pp. 85-89
MOLECULAR-GENETIC DIAGNOSIS OF A FAMILY WITH HYPERCHOLESTEROLEMIA BY A MISMATCHED PCR-RFLP METHOD FOR GENOTYPING SINGLE-BASE SUBSTITUTION OF THE LDL-RECEPTOR GENE
Authors: YAMAKI E HIRAYAMA T WU LL HOPKINS PN WILLIAMS RR EMI M
Citation: E. Yamaki et al., MOLECULAR-GENETIC DIAGNOSIS OF A FAMILY WITH HYPERCHOLESTEROLEMIA BY A MISMATCHED PCR-RFLP METHOD FOR GENOTYPING SINGLE-BASE SUBSTITUTION OF THE LDL-RECEPTOR GENE, Japanese Heart Journal, 39(5), 1998, pp. 681-686
TYPE-III HYPERLIPIDEMIA AND LIPOPROTEIN REMNANTS IN EARLY-ONSET FAMILY CORONARY-ARTERY DISEASE
Authors: HOPKINS PN WU LL WILLIAMS RR BAKER TL LEARY T WANG T NAKAJIMA K
Citation: Pn. Hopkins et al., TYPE-III HYPERLIPIDEMIA AND LIPOPROTEIN REMNANTS IN EARLY-ONSET FAMILY CORONARY-ARTERY DISEASE, Circulation, 98(17), 1998, pp. 4146-4146
HOMOCYSTEINE IS ASSOCIATED WITH ARTERIAL STIFFNESS IN CURRENT SMOKERS- THE NHLBI FAMILY HEART-STUDY
Authors: ARNETT DK TSAI MY EVANS GW WILLIAMS RR PROVINCE MA
Citation: Dk. Arnett et al., HOMOCYSTEINE IS ASSOCIATED WITH ARTERIAL STIFFNESS IN CURRENT SMOKERS- THE NHLBI FAMILY HEART-STUDY, Circulation, 97(8), 1998, pp. 29-29
A WORLD-WIDE-WEB SITE FOR LOW-DENSITY-LIPOPROTEIN RECEPTOR GENE-MUTATIONS IN FAMILIAL HYPERCHOLESTEROLEMIA - SEQUENCE-BASED, TABULAR, AND DIRECT SUBMISSION DATA HANDLING
Authors: WILSON DJ GAHAN M HADDAD L HEATH K WHITTAL RA WILLIAMS RR HUMPHRIES SE DAY INM
Citation: Dj. Wilson et al., A WORLD-WIDE-WEB SITE FOR LOW-DENSITY-LIPOPROTEIN RECEPTOR GENE-MUTATIONS IN FAMILIAL HYPERCHOLESTEROLEMIA - SEQUENCE-BASED, TABULAR, AND DIRECT SUBMISSION DATA HANDLING, The American journal of cardiology, 81(12), 1998, pp. 1509
LIPOPROTEIN(A) INTERACTIONS WITH LIPID AND NONLIPID RISK-FACTORS IN EARLY FAMILIAL CORONARY-ARTERY DISEASE
Authors: HOPKINS PN WU LL HUNT SC JAMES BC VINCENT GM WILLIAMS RR
Citation: Pn. Hopkins et al., LIPOPROTEIN(A) INTERACTIONS WITH LIPID AND NONLIPID RISK-FACTORS IN EARLY FAMILIAL CORONARY-ARTERY DISEASE, Arteriosclerosis, thrombosis, and vascular biology, 17(11), 1997, pp. 2783-2792
SPECIFYING PRESSURE TRANSDUCERS THAT MATCH APPLICATION NEEDS
Authors: WILLIAMS RR
Citation: Rr. Williams, SPECIFYING PRESSURE TRANSDUCERS THAT MATCH APPLICATION NEEDS, Instrumentation & control systems, 70(11), 1997, pp. 81-84
SEGREGATION ANALYSIS OF CARDIOVASCULAR REACTIVITY TO LABORATORY STRESSORS
Authors: CHENG LSC CARMELLI D HUNT SC WILLIAMS RR
Citation: Lsc. Cheng et al., SEGREGATION ANALYSIS OF CARDIOVASCULAR REACTIVITY TO LABORATORY STRESSORS, Genetic epidemiology, 14(1), 1997, pp. 35-49
EFFECT OF DIFFERENT TYPES AND CONCENTRATIONS OF PLANT GROWTH-RETARDANTS ON STURTS DESERT PEA (SWAINSONA-FORMOSA)
Authors: HAMID MM WILLIAMS RR
Citation: Mm. Hamid et Rr. Williams, EFFECT OF DIFFERENT TYPES AND CONCENTRATIONS OF PLANT GROWTH-RETARDANTS ON STURTS DESERT PEA (SWAINSONA-FORMOSA), Scientia horticulturae, 71(1-2), 1997, pp. 79-85
TRANSLOCATION OF PACLOBUTRAZOL AND GIBBERELLIC-ACID IN STURT DESERT PEA (SWAINSONA-FORMOSA)
Authors: HAMID MM WILLIAMS RR
Citation: Mm. Hamid et Rr. Williams, TRANSLOCATION OF PACLOBUTRAZOL AND GIBBERELLIC-ACID IN STURT DESERT PEA (SWAINSONA-FORMOSA), Plant growth regulation, 23(3), 1997, pp. 167-171
ABSENCE OF A PHARMACOKINETIC INTERACTION BETWEEN INTRAVENOUS THEOPHYLLINE AND ORALLY-ADMINISTERED LEVOFLOXACIN
Authors: GISCLON LG CURTIN CR FOWLER CL WILLIAMS RR HAFKIN B NATARAJAN J
Citation: Lg. Gisclon et al., ABSENCE OF A PHARMACOKINETIC INTERACTION BETWEEN INTRAVENOUS THEOPHYLLINE AND ORALLY-ADMINISTERED LEVOFLOXACIN, Journal of clinical pharmacology, 37(8), 1997, pp. 744-750
A MULTICENTER, RANDOMIZED STUDY COMPARING THE EFFICACY AND SAFETY OF INTRAVENOUS AND OR ORAL LEVOFLOXACIN VERSUS CEFTRIAXONE AND/OR CEFUROXIME AXETIL IN TREATMENT OF ADULTS WITH COMMUNITY-ACQUIRED PNEUMONIA/
Authors: FILE TM SEGRETI J DUNBAR L PLAYER R KOHLER R WILLIAMS RR KOJAK C RUBIN A
Citation: Tm. File et al., A MULTICENTER, RANDOMIZED STUDY COMPARING THE EFFICACY AND SAFETY OF INTRAVENOUS AND OR ORAL LEVOFLOXACIN VERSUS CEFTRIAXONE AND/OR CEFUROXIME AXETIL IN TREATMENT OF ADULTS WITH COMMUNITY-ACQUIRED PNEUMONIA/, Antimicrobial agents and chemotherapy, 41(9), 1997, pp. 1965-1972
PHARMACOKINETICS AND SAFETY OF ORAL LEVOFLOXACIN IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INDIVIDUALS RECEIVING CONCOMITANT ZIDOVUDINE
Authors: CHIEN SC CHOW AT ROGGE MC WILLIAMS RR HENDRIX CW
Citation: Sc. Chien et al., PHARMACOKINETICS AND SAFETY OF ORAL LEVOFLOXACIN IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INDIVIDUALS RECEIVING CONCOMITANT ZIDOVUDINE, Antimicrobial agents and chemotherapy, 41(8), 1997, pp. 1765-1769
ABSENCE OF AGE AND GENDER EFFECTS ON THE PHARMACOKINETICS OF A SINGLE500-MILLIGRAM ORAL DOSE OF LEVOFLOXACIN IN HEALTHY-SUBJECTS
Authors: CHIEN SC CHOW AT NATARAJAN J WILLIAMS RR WONG FA ROGGE MC NAYAK RK
Citation: Sc. Chien et al., ABSENCE OF AGE AND GENDER EFFECTS ON THE PHARMACOKINETICS OF A SINGLE500-MILLIGRAM ORAL DOSE OF LEVOFLOXACIN IN HEALTHY-SUBJECTS, Antimicrobial agents and chemotherapy, 41(7), 1997, pp. 1562-1565
PHARMACOKINETIC PROFILE OF LEVOFLOXACIN FOLLOWING ONCE-DAILY 500-MILLIGRAM ORAL OR INTRAVENOUS DOSES
Authors: CHIEN SC ROGGE MC GISCLON LG CURTIN C WONG F NATARAJAN J WILLIAMS RR FOWLER CL CHEUNG WK CHOW AT
Citation: Sc. Chien et al., PHARMACOKINETIC PROFILE OF LEVOFLOXACIN FOLLOWING ONCE-DAILY 500-MILLIGRAM ORAL OR INTRAVENOUS DOSES, Antimicrobial agents and chemotherapy, 41(10), 1997, pp. 2256-2260
RESIDUES OF OXYTETRACYCLINE IN CULTURED JUVENILE BLUE SHRIMP, PENAEUS-STYLIROSTRIS (CRUSTACEA, DECAPOD), FED MEDICATED FEED FOR 14 DAYS
Authors: MOHNEY LL WILLIAMS RR BELL TA LIGHTNER DV
Citation: Ll. Mohney et al., RESIDUES OF OXYTETRACYCLINE IN CULTURED JUVENILE BLUE SHRIMP, PENAEUS-STYLIROSTRIS (CRUSTACEA, DECAPOD), FED MEDICATED FEED FOR 14 DAYS, Aquaculture, 149(3-4), 1997, pp. 193-202
Risultati: 1-25 | 26-50 | 51-63